MPI Research, inviCRO, and 3D Imaging, have opened its new Translational Imaging Center at the global headquarters of MPI Research in Mattawan, Mich. The facility will be used to accelerate pharmaceutical discovery and development of new and improved therapeutics. The 10,000 sq ft, two-story facility features the first commercially available cyclotron (pictured at left), which provides new opportunities for scientists to accelerate the drug development process through the utilization of radioisotopes in molecular imaging to track distribution and efficacy of drug candidates.
The partnership between MPI Research, inviCRO, and 3D Imaging offers a combination of translational equipment and expertise to generate the images and data sets needed to enhance drug development decisions. MPI Research provides contract research services, while inviCRO provides a range of imaging services and software solutions. 3D Imaging operates the cyclotron, bringing new radiochemistry to drug development research.
The three organizations began the project in September 2013, and the cyclotron arrived in February 2014.
Source: MPI Research